[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[2]Municipal Hospital Affiliated to Medical School of Taizhou University,Taizhou318000,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[3]Ningbo Medical Centre Li Huili Hospital,Ningbo315041,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[4]College of Information Science and Computer Engineering,Wenzhou Medical University,Wenzhou325035,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
[1]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou325035,China;
Reactive oxygen species; Cerebral ischemiareperfusion injury; Stroke; Dual-antioxidant mechanism; Chalcones; Antioxidants; Oxidative stress; NRF2/ARE;